Osteocalcin metabolism in the pulmonary circulation

The aim of this study was to evaluate the role of the pulmonary vessel endothelium in the removal of circulating osteocalcin, by measuring the osteocalcin levels in serum from pulmonary and radial artery blood from 39 patients undergoing aorto‐coronary bypass. Because of the discrepancies between me...

Full description

Saved in:
Bibliographic Details
Published in:Clinical physiology (Oxford) Vol. 20; no. 2; pp. 122 - 125
Main Authors: ALIBERTI, G, PULIGNANO, I, PROIETTA, M, TRITAPEPE, L, CIGOGNETTI, L, MENICHETTI, A, RUSSO, A, DE MICHELE, L. V, CORVISIERI, P, MINISOLA, S
Format: Journal Article
Language:English
Published: Oxford UK Blackwell Science Ltd 01-03-2000
Blackwell Science
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to evaluate the role of the pulmonary vessel endothelium in the removal of circulating osteocalcin, by measuring the osteocalcin levels in serum from pulmonary and radial artery blood from 39 patients undergoing aorto‐coronary bypass. Because of the discrepancies between methods of measurement, two methods were used. Significant differences were observed in group A (n = 18), tested with heterologous radioimmunoassay (2·85 ± 0·67 μg l−1 in the pulmonary versus 2·69 ± 0·67 μg l−1 in the radial artery serum, P<0·001) and in group B (n = 21), tested with a two‐site immunoradiometric assay (5·22 ± 1·46 versus 4·93 ± 1·36 μg l−1, P<0·01). The percentage differences were –5·54 ± 4·76% (P<0·001) in group A and –4·99 ± 8·13% (P<0·01) in group B; the comparison between the percentage differences was not significant. These different osteocalcin concentrations between the two vascular compartments were considered a marker of osteocalcin degradation. Therefore, the study seems to demonstrate that, as well as kidney, liver and bone, the lung is a relevant site of osteocalcin catabolism. The proteolytic activity of pulmonary vessel endothelium seems to involve about 5% of the circulating peptide.
Bibliography:istex:1B19DDD3EC9315FF8488ECF263531E8B1BC7A01B
ArticleID:CPF236
ark:/67375/WNG-BVW05QRG-H
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0144-5979
1365-2281
DOI:10.1046/j.1365-2281.2000.00236.x